Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xenetic Biosciences, Inc. - Common Stock
(NQ:
XBIO
)
1.930
-0.060 (-3.02%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenetic Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results
November 10, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference
October 11, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. Reports Second Quarter 2023 Financial Results
August 11, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. to Participate in the Virtual Investor Summer Spotlight Series
July 05, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 20, 2023
Gainers
Via
Benzinga
Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences
↗
May 16, 2023
Via
Benzinga
Xenetic Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullison
May 03, 2023
Via
ACCESSWIRE
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 12, 2023
Via
Benzinga
Xenetic Biosciences, Inc. Reports Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. to Present at the Virtual Investor NETs in Cancer Spotlight Event
March 16, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. to Present at the Virtual Investor 2023 Companies to Watch Event
January 05, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
May 12, 2023
Via
ACCESSWIRE
Xenetic Biosciences, Inc. Bolsters R&D and Regulatory Expertise with Appointment of Reid P. Bissonnette, Ph.D. as Executive Consultant for Translational Research and Development
May 04, 2023
Via
ACCESSWIRE
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
↗
April 13, 2023
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of...
Via
Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
↗
April 13, 2023
A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
Via
Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
↗
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
↗
April 11, 2023
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 11, 2023
Via
Benzinga
Xenetic Biosciences, Inc. Announces Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
April 11, 2023
Via
ACCESSWIRE
US Judge Weighs Nationwide Ban On Abortion Pills
↗
March 16, 2023
U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 02, 2023
Via
Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
↗
March 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 06, 2023
Via
Benzinga
Xenetic Biosciences, Inc. Announces Notice of Allowance for Canadian Patent Covering Use of DNase Enzyme for Preventing or Ameliorating Toxicity Associated with Chemotherapy
January 17, 2023
Via
ACCESSWIRE
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
↗
December 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
